aTyr Pharma (LIFE) – Analyst Ratings
-
aTyr Pharma (LIFE) PT Lowered to $16 at RBC Capital
-
aTyr Pharma (LIFE) PT Raised to $20 at Piper Sandler, 'Efzofitimod - A Diamond in the Rough'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to LIFE Stock Lookup